Recent Company News

• 07:42 AM ET Jul 08, 2026
  

  UK is close to agreement with Daiichi Sankyo and AstraZeneca for Enhertu - Bloomberg (¥2717.0000, 0)

• 09:29 PM ET Jul 02, 2026
  

  StreetAccount Sector Summary - China Healthcare June Recap

• 11:39 AM ET Jun 29, 2026
  

  China announces preliminary results of 2026 NRDL adjustment, 557 passed for basic medical insurance, 54 passed for commercial insurance list

• 02:37 AM ET Jun 29, 2026
  

  AstraZeneca and Daiichi Sankyo's Enhertu obtains EU approval for previously treated HER2-positive metastatic solid tumors (¥2614.0000, 0)

• 02:05 AM ET Jun 29, 2026
  

  AstraZeneca and Daiichi Sankyo's Datroway recommended for approval in EU for TNBC

• 08:51 AM ET Jun 26, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 08:34 AM ET Jun 26, 2026
  

  EMA CHMP publishes summary of opinions for June 2026 meeting

• 07:06 AM ET Jun 26, 2026
  

  EU's CHMP adopted a positive opinion, recommending a change to the terms of the marketing authorisation for the medicinal product Datroway (¥2535.5000, 0)

• 07:05 AM ET Jun 26, 2026
  

  Datroway recommended for approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer who are not candidates for immunotherapy (¥2535.5000, 0)

• 07:03 AM ET Jun 26, 2026
  

  EU's CHMP adopted a positive opinion, recommending the granting of a marketing authorisation for Ascend GmbH's medicinal product Denosumab Ascend